Encouraged by strong investor interest in sub-sectors like pharma services, health care bankers are optimistic that M&A will pick up in the latter half of 2024.
Why it matters: After a lackluster 2023 and a tepid Q1, valuation expectations are settling and dealmakers are ready to put pen to paper.
Bankers spoke about the 2024 M&A outlook under Chatham House rules at McDermott Will & Emery's Healthcare Private Equity conference in Miami this month.
